# Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia

> **NCT00985777** · PHASE1 · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 26 (actual)

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** Vitamin E δ-Tocotrienol

## Key facts

- **NCT ID:** NCT00985777
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2015-06
- **Final completion:** 2016-02
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2016-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00985777

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00985777, "Vitamin E δ-Tocotrienol Administered to Subjects With Resectable Pancreatic Exocrine Neoplasia". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00985777. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*